Lam, Tony K. T.
Cherney, David Z. I.
Article History
First Online: 6 August 2018
Competing interests
: D.Z.I.C. has received consulting fees or speaking honorarium or both from Janssen, Boehringer Ingelheim-Eli, Lilly, AstraZeneca, Merck and Sanofi and has received operating funds from Janssen, Boehringer Ingelheim-Eli, Lilly, AstraZeneca and Merck.